Cargando…

The Role of Haematological Parameters in Predicting the Response To Radical Chemoradiotherapy in Patients with Anal Squamous Cell Cancer

BACKGROUND: Historically, the treatment of choice for anal cancer had been abdominoperineal resection (APR). Radical radiotherapy with concurrent 5-fluorouracil plus mitomycin C chemotherapy was later established as standard therapy, although with a failure rate of 20–30%. The aim of this study was...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stojanovic-Rundic, Suzana, Marinkovic, Mladen, Cavic, Milena, Karapandzic, Vesna Plesinac, Gavrilovic, Dusica, Jankovic, Radmila, de Voer, Richarda M., Castellvi-Bel, Sergi, Krivokapic, Zoran
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sciendo 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8647797/ https://www.ncbi.nlm.nih.gov/pubmed/34626531 http://dx.doi.org/10.2478/raon-2021-0039

Ejemplares similares

Exploring novel genetic and hematological predictors of response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer
por: Marinkovic, Mladen, et al.
Publicado: (2023)

Data-Independent Acquisition Mass Spectrometry Analysis of FFPE Rectal Cancer Samples Offers In-Depth Proteomics Characterization of the Response to Neoadjuvant Chemoradiotherapy
por: Stanojevic, Aleksandra, et al.
Publicado: (2023)

Comparison of Different Machine Learning Models in Prediction of Postirradiation Recurrence in Prostate Carcinoma Patients
por: Marinkovic, Mladen, et al.
Publicado: (2022)

Acute chemoradiotherapy toxicity in cervical cancer patients
por: Radojevic, Marija Zivkovic, et al.
Publicado: (2020)

Molecular signature of response to preoperative radiotherapy in locally advanced breast cancer
por: Tanić, Miljana, et al.
Publicado: (2018)

Prognostic Factors for Post-Recurrence Survival in Stage II and III Colorectal Carcinoma Patients
por: Nikolic, Neda, et al.
Publicado: (2021)

Follow-Up Imaging of Inflammatory Myofibroblastic Tumor of the Uterus and Its Spontaneous Regression
por: Markovic Vasiljkovic, Biljana, et al.
Publicado: (2016)

Adynamic and dynamic muscle transposition techniques for anal incontinence
por: Barišić, Goran, et al.
Publicado: (2014)

Gestational Diabetes Mellitus and Antenatal Corticosteroid Therapy—A Narrative Review of Fetal and Neonatal Outcomes
por: Babović, Ivana R., et al.
Publicado: (2022)

Evaluation of Clinical and Genetic Determinants of Treatment OutCome In EGFR Mutation Positive Advanced Lung Adenocarcinoma
por: Jokic, Vera, et al.
Publicado: (2022)

Cross-Talk Between Tumor Cells Undergoing Epithelial to Mesenchymal Transition and Natural Killer Cells in Tumor Microenvironment in Colorectal Cancer
por: Vuletić, Ana, et al.
Publicado: (2021)

Effective treatment of anal cancer in the elderly with low-dose chemoradiotherapy
por: Charnley, N, et al.
Publicado: (2005)

A Suzuki-type multivalued contraction on weak partial metric spaces and applications
por: Aydi, Hassen, et al.
Publicado: (2018)

Multiparametric MRI as an outcome predictor for anal canal cancer managed with chemoradiotherapy
por: Jones, Michael, et al.
Publicado: (2015)

Chemoradiotherapy with capecitabine for locally advanced anal carcinoma: an alternative treatment option
por: Meulendijks, D, et al.
Publicado: (2014)

Sarcopenia Is Associated With Hematologic Toxicity During Chemoradiotherapy in Patients With Anal Carcinoma
por: Martin, Daniel, et al.
Publicado: (2020)

IAP inhibitor plus chemoradiotherapy for the treatment of bulky anal canal carcinoma
por: De Felice, Francesca, et al.
Publicado: (2023)

EGFR mutation testing from pleural effusions of non-small cell lung cancer patients at the institute for oncology and radiology of Serbia
por: Vukovic, Miodrag, et al.
Publicado: (2023)

Modeling early haematologic adverse events in conformal and intensity-modulated pelvic radiotherapy in anal cancer
por: Robinson, Maxwell, et al.
Publicado: (2015)

FDG-PET metabolic response predicts outcomes in anal cancer managed with chemoradiotherapy
por: Day, F L, et al.
Publicado: (2011)

Chemoradiotherapy in squamous cell carcinoma of the anal canal: a single institution experience
por: Kim, Kyung Hwan, et al.
Publicado: (2013)

Systematic review of outcome measures following chemoradiotherapy for the treatment of anal cancer (CORMAC)
por: Fish, R., et al.
Publicado: (2018)

Combined Contribution of Endothelial Relaxing Autacoides in the Rat Femoral Artery Response to CPCA: An Adenosine A(2) Receptor Agonist
por: Radenković, Miroslav, et al.
Publicado: (2012)

Alloxan-induced diabetes alters rat common carotid artery response to adenosine
por: Radenković, Miroslav, et al.
Publicado: (2012)

Oxidative and Nitrosative Stress in Stable Renal Transplant Recipients with Respect to the Immunosuppression Protocol – Differences or Similarities?
por: Cvetković, Tatjana, et al.
Publicado: (2015)

Peritoneal Dialysis in Neonates with Extremely Low Body Weight at Birth: New Modality of Using IV Cannula for Peritoneal Access
por: Stojanovic, Vesna, et al.
Publicado: (2013)

Enhanced Recovery in Thoracic Surgery: A Review
por: Dinic, Vesna D., et al.
Publicado: (2018)

Alternative chemoradiotherapy in anal carcinoma patients with mutations in thymidylate synthase and dihydropyrimidine dehydrogenase genes
por: Saif, MW, et al.
Publicado: (2021)

Real World Overall Survival of Patients With Metastatic Renal Cell Carcinoma Treated With Only Available Sunitinib and Pazopanib in First-Line Setting
por: Nikic, Predrag, et al.
Publicado: (2022)

Candidate Gene Discovery in Hereditary Colorectal Cancer and Polyposis Syndromes–Considerations for Future Studies
por: te Paske, Iris B. A. W., et al.
Publicado: (2020)

Detection of humoral and cellular immune response to anti-SARS-CoV-2 BNT162b2 vaccine in breastfeeding women and naïve and previously infected individuals
por: Cavic, Milena, et al.
Publicado: (2023)

High survivin expression as a risk factor in patients with anal carcinoma treated with concurrent chemoradiotherapy
por: Fraunholz, Ingeborg, et al.
Publicado: (2012)

Oxygen-enhanced MRI MOLLI T1 mapping during chemoradiotherapy in anal squamous cell carcinoma
por: Bluemke, Emma, et al.
Publicado: (2020)

High-grade neuroendocrine small-cell carcinoma of the anal canal: Long-term remission with chemoradiotherapy
por: Hajjar, Roy, et al.
Publicado: (2021)

The impact of bone marrow irradiation dose on acute haematologic toxicity in cervical cancer patients treated with concurrent chemoradiotherapy
por: Chen, Min, et al.
Publicado: (2023)

Lagging Immune Response to Haemophilus influenzae Serotype b (Hib) Conjugate Vaccine after the Primary Vaccination with Hib of Infants in The Netherlands
por: Schouls, Leo, et al.
Publicado: (2020)

Monoallelic NTHL1 Loss-of-Function Variants and Risk of Polyposis and Colorectal Cancer
por: Elsayed, Fadwa A., et al.
Publicado: (2020)

HAEMATOLOGY IN TROPICAL AREAS: CLINICS IN HAEMATOLOGY
Publicado: (1983)

Humoral immunoreactivity to gliadin and to tissue transglutaminase is present in some patients with multiple myeloma
por: Juranic, Zorica, et al.
Publicado: (2008)

High IDO1 Expression Is Associated with Poor Outcome in Patients with Anal Cancer Treated with Definitive Chemoradiotherapy
por: Mitra, Devarati, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_na6e7d8g22kepdb6nj18ekisca